Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratinocytes are the primary structural and functional cells of the epidermis, constituting approximately 90% of the skin's outermost layer [1, 13]. Their fundamental biological role is the creation of a semi-permeable barrier that protects the body from mechanical injury, pathogens, and dehydration through the production of keratin and lipids [2, 9]. Beyond keratinocytes, the skin contains specialized cells such as melanocytes for UV protection, Langerhans cells for immune surveillance, and Merkel cells for sensory perception [3, 4]. Dysregulation of these cell populations is central to the pathogenesis of various dermatological diseases, including psoriasis, atopic dermatitis, and skin cancers like squamous cell carcinoma [7, 12]. Although these cells represent a tissue category rather than a single molecular target, they house numerous receptors—such as retinoic acid receptors (RAR) and vitamin D receptors (VDR)—that are targeted by pharmacological agents [8, 9]. Drugs like tretinoin and calcipotriene interact with these targets to modulate cell proliferation and differentiation, while modern biologics target the cytokine signaling pathways that influence skin cell behavior in inflammatory conditions [10, 15].
Pharmacological agents targeting these cells typically act as agonists for nuclear receptors such as retinoic acid receptors (RAR) and vitamin D receptors (VDR), or as inhibitors of cytokine signaling pathways (e.g., IL-17, IL-4/13) to normalize cell proliferation, differentiation, and inflammatory responses [8, 10, 12].
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratinocytes and other skin cell types.